← Eichor
Study identifier: NCT05966493 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Condition: Persistent Corneal Epithelial Defect  ·  Sponsor: Glaukos Corporation

PhasePhase 2
Planned participants84
Who can joinAll sexes, 2 Years to no upper limit
Healthy volunteersNo

About this study

This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCED). The objectives of the study are to evaluate the safety and efficacy of NEXAGON in this population.

This description comes directly from the study's public registry record.

Talk to the study team

Study Director  ·  949-739-8749  ·  ClinicalResearch@Glaukos.com

Always discuss trial participation with your own doctor first.

Locations (28)

Glaukos Investigative SiteDothan, Alabama, United StatesRecruiting
Glaukos Investigative SitePetaluma, California, United StatesRecruiting
Glaukos Investigative SiteTorrance, California, United StatesRecruiting
Glaukos Investigative SiteColorado Springs, Colorado, United StatesRecruiting
Glaukos Investigative SiteGrand Junction, Colorado, United StatesRecruiting
Glaukos Investigative SiteBradenton, Florida, United StatesRecruiting
Glaukos Investigative SiteFort Myers, Florida, United StatesRecruiting
Glaukos Investigative SiteSouth Miami, Florida, United StatesRecruiting
Glaukos Investigative SiteAtlanta, Georgia, United StatesRecruiting
Glaukos Investigative SiteCarmel, Indiana, United StatesRecruiting
Glaukos Investigative SiteFraser, Michigan, United StatesRecruiting
Glaukos Investigative SiteKansas City, Missouri, United StatesRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05966493